Richard Kincaid
Net worth: 394 575 $ as of 2026-05-30
Net worth: 394 575 $ as of 2026-05-30
Richard Patrick Kincaid is currently Chairman, President & Chief Executive Officer at Healios N.A., Inc. since 2023.
He is an Independent Outside Director at Metaplanet, Inc. starting in 2025.
He serves as Chief Financial Officer & Director at Healios KK since 2019 and is a Board Manager at Saisei Ventures LLC.
Formerly, Mr. Kincaid was Director at Nezu Master Strategy Feeder Ltd. He was Chief Operating Officer & Partner at Nezu Asia Capital Management Ltd. from 2011 to 2013.
From 2003 to 2019, he was COO & Management Committee Member at Nezu Asia Capital Management (Singapore) Pte Ltd. Mr. Kincaid completed undergraduate studies at Harvard University in 1999.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HEALIOS KK 0.14% | 2025-12-30 | 187,500 ( 0.14% ) | 394 575 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| HEALIOS K.K. | Director of Finance/CFO | 2019-07-15 |
| METAPLANET INC. | Director/Board Member | 2025-03-23 |
Healios N.A., Inc. | Chief Executive Officer | - |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Nezu Asia Capital Management (Singapore) Pte Ltd.
Nezu Asia Capital Management (Singapore) Pte Ltd. Investment ManagersFinance Nezu Asia SG’s investment philosophy is based on GARP and focuses on growth and capital efficiency, primarily in the business process outsourcing (including software), MedTech, and consumer sectors. Their portfolio is micro, fundamental, and backed up by several hundred company visits per annum as the cornerstone of the investment process. | President | 2019-11-30 |
Nezu Master Strategy Feeder Ltd.
Nezu Master Strategy Feeder Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as hedge fund | Director/Board Member | - |
Nezu Asia Capital Management Ltd.
Nezu Asia Capital Management Ltd. Investment ManagersFinance Nezu HK is an active manager which aims to achieve high risk-adjusted returns for investors through fundamental research, their market experience and risk management process. | Chief Operating Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metaplanet, Inc.
Metaplanet, Inc. Investment Banks/BrokersFinance Provides bitcoin treasury services and operates hotels | Finance |
Nezu Asia Capital Management Ltd.
Nezu Asia Capital Management Ltd. Investment ManagersFinance Nezu HK is an active manager which aims to achieve high risk-adjusted returns for investors through fundamental research, their market experience and risk management process. | Finance |
Nezu Asia Capital Management (Singapore) Pte Ltd.
Nezu Asia Capital Management (Singapore) Pte Ltd. Investment ManagersFinance Nezu Asia SG’s investment philosophy is based on GARP and focuses on growth and capital efficiency, primarily in the business process outsourcing (including software), MedTech, and consumer sectors. Their portfolio is micro, fundamental, and backed up by several hundred company visits per annum as the cornerstone of the investment process. | Finance |
Healios KK
Healios KK Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of cell therapy and regenerative medicine products | Health Technology |
Nezu Master Strategy Feeder Ltd.
Nezu Master Strategy Feeder Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as hedge fund | Miscellaneous |
Healios N.A., Inc. | |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Finance |
Select your edition
All financial news and data tailored to specific country editions